NCT06247566View on ClinicalTrials.gov

68Ga-Pentixafor PET/CT for Guiding Surgical Treatment of Primary Aldosteronism With Bilateral Adrenal Lesions

CompletedOBSERVATIONAL
Enrollment

83

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

July 1, 2023

Study Completion Date

July 1, 2023

Conditions
Primary Aldosteronism With Bilateral Adrenal Lesions
Trial Locations (1)

410008

Department of Urology, Xiangya Hospital, Central South University, Changsha

All Listed Sponsors
lead

Central South University

OTHER

NCT06247566 - 68Ga-Pentixafor PET/CT for Guiding Surgical Treatment of Primary Aldosteronism With Bilateral Adrenal Lesions | Biotech Hunter | Biotech Hunter